Blueprint Medicines Corp

NASDAQ:BPMC  
106.05
+3.09 (+3.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.40B
Current PE18.80
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$44.28 Million
Adjusted EPS-$1.53
See more estimates
10-Day MA$100.44
50-Day MA$91.50
200-Day MA$96.41
See more pivots

Blueprint Medicines Corp Stock, NASDAQ:BPMC

45 Sidney Street, 45 Sidney Street, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.374.7580
Number of Employees: 429

Description

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.